PAVM
PAVmed Inc.Company with tickers: PAVM
CIK
1624326
CUSIP
70387R502
Shares Outstanding
7,159,034
13F Activity (30d)
13 filings
13 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $22,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Cost of Revenue | $97,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $1,388,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Operating Income | $-8,035,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Net Income | $-60,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Basic) | $-4.42 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Diluted) | $-4.42 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |